Philip A. Laskawy
Known title: DirectorCIK: 0001099296
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Loews Stock Valuation Reviewed After 92% Five-Year Gain. Recent analysis suggests Loews stock appears reasonably valued following a 92% increase over the past five years. This long-term performance provides context for the current share price within its 52-week range. The commentary focuses on the stock's historical growth rather than immediate short-term movements.
Transaction History
| HSIC | ▲ Buy | Grant | 2,577 | $0 | 3/6/2026 | View on chart |
| HSIC | ▼ Sell | Open Market | 2,844 | $229K | 3/5/2026 | View on chart |
| HSIC | ▼ Sell | Open Market | 2,604 | $185K | 3/19/2025 | View on chart |
| HSIC | ▲ Buy | Grant | 2,844 | $0 | 3/4/2025 | View on chart |
| HSIC | ▼ Sell | Open Market | 4,278 | $326K | 3/5/2024 | View on chart |
| HSIC | ▲ Buy | Grant | 2,604 | $0 | 3/4/2024 | View on chart |
| HSIC | ▼ Sell | Open Market | 6,405 | $504K | 3/3/2023 | View on chart |
| L | ▲ Buy | Option Exercise | 2,250 | $99K | 3/1/2023 | View on chart |
| L | ▼ Sell | Open Market | 625 | $38K | 3/1/2023 | View on chart |
| L | ▼ Sell | Other | 1,625 | $99K | 3/1/2023 | View on chart |
| HSIC | ▲ Buy | Grant | 2,250 | $0 | 3/1/2023 | View on chart |
| L | ▲ Buy | Option Exercise | 2,250 | $91K | 12/1/2022 | View on chart |
| L | ▼ Sell | Open Market | 698 | $41K | 12/1/2022 | View on chart |
| L | ▼ Sell | Other | 1,552 | $91K | 12/1/2022 | View on chart |
| L | ▲ Buy | Option Exercise | 2,250 | $93K | 9/1/2022 | View on chart |
| L | ▼ Sell | Other | 1,678 | $93K | 9/1/2022 | View on chart |
| L | ▼ Sell | Open Market | 572 | $31K | 9/1/2022 | View on chart |
| L | ▲ Buy | Option Exercise | 2,250 | $90K | 6/1/2022 | View on chart |
| L | ▼ Sell | Open Market | 868 | $56K | 6/1/2022 | View on chart |
| L | ▼ Sell | Open Market | 15 | $982 | 6/1/2022 | View on chart |
| L | ▼ Sell | Other | 1,367 | $90K | 6/1/2022 | View on chart |
| HSIC | ▲ Buy | Grant | 2,028 | $0 | 3/16/2022 | View on chart |
| HSIC | ▼ Sell | Open Market | 2,790 | $245K | 3/7/2022 | View on chart |
| L | ▲ Buy | Option Exercise | 2,250 | $89K | 3/1/2022 | View on chart |
| L | ▼ Sell | Other | 1,453 | $89K | 3/1/2022 | View on chart |
| L | ▼ Sell | Open Market | 797 | $48K | 3/1/2022 | View on chart |
| L | ▲ Buy | Option Exercise | 1,500 | $57K | 12/1/2021 | View on chart |
| L | ▼ Sell | Other | 1,041 | $57K | 12/1/2021 | View on chart |
| L | ▼ Sell | Open Market | 459 | $25K | 12/1/2021 | View on chart |
| L | ▲ Buy | Option Exercise | 1,500 | $53K | 9/1/2021 | View on chart |
| L | ▼ Sell | Other | 939 | $53K | 9/1/2021 | View on chart |
| L | ▼ Sell | Open Market | 561 | $31K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Henry Schein Extends Credit Facility Amid Market Growth Projections
Henry Schein recently extended its credit facility, a move that supports its financial flexibility. This corporate action comes as the dental implants market is projected to grow from $12.79 billion in 2026 to $17.67 billion by 2031. The company also marked 25 years of its Henry Schein Cares initiative. These developments provide context for the stock's current position near its support level.
Henry Schein Extends Credit Facility Amid Market Growth Projections. Henry Schein recently extended its credit facility, a move that supports its financial flexibility. This corporate action comes as the dental implants market is projected to grow from $12.79 billion in 2026 to $17.67 billion by 2031. The company also marked 25 years of its Henry Schein Cares initiative. These developments provide context for the stock's current position near its support level.